Testosterone Therapy in Men with Prostate Cancer: A Revolution in Understanding

Abraham Morgentaler, M.D.

Associate Professor, Harvard Medical School; Staff, Beth Israel Deaconess Medical Center

History of the concern re T and prostate cancer (PCa). Current status of the contraindication to use T therapy in men with PCa. Does testosterone cause PCa?  Do men with higher levels of T have greater risk than men with low levels? Do men on T therapy have higher risk of developing PCa. The saturation model. Evidence in men following radical prostatectomy or radiation. Evidence in men on active surveillance. My recent experiences in men with metastatic prostate cancer. How I treat. Recommendations for treatment, monitoring, and medico-legal concerns.